The effects of thiazolidinedione from the cardiologic viewpoint
Ziegler, R.
Medizinische Monatsschrift für Pharmazeuten 28(10): 365
2005
ISSN/ISBN: 0342-9601 PMID: 16245456 Document Number: 592915
Document emailed within 1 workday
Related Documents
Klein, W. 1999: Target blood pressure values from the cardiologic viewpoint Wiener Medizinische Wochenschrift 149(23-24): 625-628Yamada, K.; Kuzuya, H.; Nakano, T. 2000: Cardiovascular effects of the thiazolidinedione troglitazone Nihon Rinsho. Japanese Journal of Clinical Medicine 58(2): 435-439
Sugiyama, Y. 2002: Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 416-421
Sugiyama, Y.; Murase, K.; Ikeda, H. 2000: Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects Nihon Rinsho. Japanese Journal of Clinical Medicine 58(2): 370-375
Wang, A.-P.; Li, X.; Liu, B.-L.; Zheng, Y.; Zheng, C.; Lin, J.; Huang, G.; Yan, X.; Peng, J.; Zhou, Z.-G. 2009: Inhibitory effects of thiazolidinedione upon cytokine-induced apoptosis in pancreatic beta-cell line Zhonghua Yi Xue Za Zhi 89(28): 1989-1993
Salama, K.M.; Vladzimirskaia, E.V. 1978: Derivatives of 1,4-di-(thiazolidinedione-2',4'-yl-3')-butane Farmatsevtychnyi Zhurnal 4: 26-29
Tolman, K.G. 2000: Thiazolidinedione hepatotoxicity: a class effect? International Journal of Clinical Practice. Suppl 113: 29-34
Menaka, R.; Sehgal, M.; Lakshmi, M.; Bhattacharyya, A. 2010: Thiazolidinedione precipitated thyroid associated ophthalmopathy Journal of the Association of Physicians of India 58: 255-257
Yamanouchi, T. 2002: Chemical structures and pharmacological characteristics of novel non-thiazolidinedione insulin sensitizer (JTT-501, FK614) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 573-577
Mombelli, A.; Zappa, U. 1983: Effects of smoking from a medico-dental viewpoint Therapeutische Umschau. Revue Therapeutique 40(2): 121-124
Cox, P.J.; Ryan, D.A.; Hollis, F.J.; Harris, A.M.; Miller, A.K.; Vousden, M.; Cowley, H. 2000: Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(7): 772-780
Schadewaldt, H. 1981: Side effects of drugs from the viewpoint of medical history Die Medizinische Welt 32(7): 207-209
Krebs, D. 1993: Intentions and effects of the embryo protection regulation from the physician's viewpoint Zeitschrift für Arztliche Fortbildung 87(10-11): 809-813
Andersen, J. 2000: Cardiologic reliability Ugeskrift for Laeger 162(37): 4947-4948
Galati, A. 2004: The term "cardiologic rehabilitation" Monaldi Archives for Chest Disease 62(1): 59
Nakanishi, K.; Une, Y.; Haneda, T.; Okubo, H.; Tomioka, N.; Shimamura, T.; Matsushita, M.; Sato, N.; Nakajima, Y.; Uchino, J. 1996: The effects of preoperative transcatheter arterial chemoembolization (TAE) for the recurrence of hepatocellular carcinoma (HCC) from the viewpoint of consecutive tumor necrosis effect Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(11): 1412-1414
Van Viet, H.; Chevalier, P.; De Jaeger, C.; Rullière, R. 1989: Cardiologic complications related to cocaine Annales de Medecine Interne 140(8): 702-708
Siracusano, L.; Girasole, V.; Mandolfino, T. 1992: Cardiologic emergencies in oral medicine Minerva Anestesiologica 58(10): 1079-1084
Weidemann, H. 1996: Cardiologic rehabilitation. An orienting overview Zeitschrift für Arztliche Fortbildung 90(6): 479-486
Ripa, R. 1978: Calcium antagonists in cardiologic therapy Minerva Medica 69(48): 3323-3325